Valuation Sernova Biotherapeutics Inc
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1300 CAD | -3.70% |
|
-7.14% | - |
Company Valuation: Sernova Biotherapeutics Inc
Data adjusted to current consolidation scope
| Fiscal Period: October | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 326.4 | 234.5 | 243.9 | 81.33 | 59.26 | 49.09 | - | - |
| Change | - | -28.16% | 3.99% | -66.65% | -27.14% | -17.15% | - | - |
| Enterprise Value (EV) | 326.4 | 234.5 | 235.1 | 75.79 | 63.76 | 49.09 | 49.09 | 49.09 |
| Change | - | -28.16% | 0.27% | -67.77% | -15.87% | -23% | 0% | 0% |
| P/E | -41.7x | -8.89x | -5.85x | -2.5x | -3x | -4.33x | -3.25x | 0.34x |
| PBR | - | - | 18.4x | -6.28x | -1.96x | -4.33x | -3.25x | 0.38x |
| PEG | - | -0x | -0.1x | 0.1x | 0.1x | 0.1x | -0.1x | -0x |
| Capitalization / Revenue | - | - | - | - | - | - | 9.82x | 0.19x |
| EV / Revenue | - | - | - | - | - | - | 9.82x | 0.19x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.03 | -0.09 | -0.13 | -0.1 | -0.05 | -0.03 | -0.04 | 0.38 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | 5 | 255.6 |
| EBITDA | -6.669 | -24.31 | -40.06 | -31.12 | -14.68 | - | - | - |
| EBIT | -6.937 | -24.75 | -40.5 | -31.66 | -15.02 | - | - | - |
| Net income 1 | -6.966 | -24.42 | -39 | -32.19 | -15.74 | -12.83 | -19.77 | 172.7 |
| Net Debt | - | - | -8.722 | -5.544 | 4.503 | - | - | - |
| Reference price 2 | 1.2500 | 0.8000 | 0.7600 | 0.2500 | 0.1500 | 0.1300 | 0.1300 | 0.1300 |
| Nbr of stocks (in thousands) | 261,133 | 293,125 | 320,857 | 325,325 | 395,037 | 377,643 | - | - |
| Announcement Date | 2/14/22 | 1/26/23 | 1/29/24 | 12/23/24 | 12/19/25 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.33x | - | - | - | 34.61M | |
| 25.69x | 4.91x | 17.18x | 1.1% | 125B | |
| 18.64x | 2.37x | 9.09x | 2.74% | 12.77B | |
| -164.56x | 13.48x | -499.83x | -.--% | 8.71B | |
| 19.8x | 9.31x | 15.08x | 2.16% | 3.98B | |
| 17.39x | 4.66x | 9.1x | 3.52% | 1.61B | |
| 88.77x | 14.2x | 49.62x | 0.06% | 1.54B | |
| Average | 0.20x | 8.15x | -66.63x | 1.6% | 21.97B | |
| Weighted average by Cap. | 14.71x | 5.39x | -12.59x | 1.22% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SVA Stock
- Valuation Sernova Biotherapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
